Trials of drug for hepatitis scrapped after patients die: British tests cancelled after two deaths in US
The British trial could have involved 50 to 100 hepatitis B patients.
Despite adherence to the rigorous procedures demanded by the American federal drug authority for the testing of new treatments, the drug, fialuridine, has caused liver failure. Doctors now believe that the reaction was caused by some unexpected cumulative effects of the drug in the body.
Fialuridine, an anti-viral drug produced by Eli Lilly & Company, had been heralded as the cure for hepatitis B, a viral disease which affects 300 million people world-wide and can cause liver failure and death.
World experts in liver disease are shocked that a drug on trial should have had such drastic consequences for patients and disappointed that it is now almost certainly lost to medical science.
The American trial, approved by the US Food and Drug Administration, involved 20 patients, 15 of them attending the National Institute of Health in Washington, the premier research centre in the US.
Dr Allan Weinstein, vice-president of Lilly Research Laboratories, Indianapolis, said that three patients had received liver transplants, of whom two had died. Three other patients might need transplants in the future, he said.
'Right now we have two goals: to make sure that the patients involved have the best possible care and then to accumulate all the data as quickly as we can. Then we may be able to understand what has been going on.'
Eleven of the patients involved had been given fialuridine as part of an earlier trial last year. All six patients belonged to this group.
Dr Roger Williams, director of the Liver Unit at King's College Hospital, south London, who attended an international meeting of liver experts in Washington last week, said that the adverse reaction appeared to be related to the dose.
'The patients affected developed a widespread toxicity involving the liver and the damage seems to be related to a cumulative effect. It has been a great shock to everyone involved,' he said.
Hepatitis B is an infectious disease which is usually passed by sexual or blood contact. Until blood was screened for hepatitis B, people became infected via transfusions. However, the infection is more commonly associated with the sharing of needles by drug addicts and with homosexual practice. It can persist for many years and can lead to chronic hepatitis, in which liver cells are destroyed, leading to cirrhosis of the liver.
There is no effective drug currently available for hepatitis B. The only treatment, used in severe cases, is interferon, which is only 30-40 per cent effective.
- 2 Moscow voted the world's unfriendliest city
- 3 The excuses your boss is most likely to believe when you call in sick
- 4 I'm pansexual – here are the five biggest misconceptions about my sexuality
- 5 More than 11,000 Icelanders offer to house Syrian refugees to help European crisis
The one chart that shows how George Osborne is almost certainly going to be our next Prime Minister
The excuses your boss is most likely to believe when you call in sick
Bono's group has made more money from Facebook investment than from all his music
Three-year-old ultra-Orthodox Jewish children told 'the non-Jews' are 'evil' in worksheet produced by London school
Wikipedia rocked by 'rogue editors' blackmail scam targeting small businesses and celebrities
Climate change: 2015 will be the hottest year on record 'by a mile', experts say
Jeremy Corbyn calls Osama bin Laden's killing a 'tragedy' - but was it taken out of context?
If these extraordinarily powerful images of a dead Syrian child washed up on a beach don’t change Europe’s attitude to refugees, what will?
Tony Blair attacks Jeremy Corbyn's 'Alice In Wonderland' politics
Theresa May says migrants should be banned from entering the UK unless they have jobs lined up
If you're not already angry about the refugee crisis, here's a history lesson to remind you why you really should be
£40000 - £42000 per annum: Recruitment Genius: This is an exciting opportunity...
£35000 - £40000 per annum: Recruitment Genius: This IT support company has a n...
Negotiable: Recruitment Genius: A works engineer is required in a progressive ...
£21000 - £25000 per annum: Recruitment Genius: Our client is seeking someone w...